412 related articles for article (PubMed ID: 16968504)
1. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Jensen DM; Pace SC; Soffer E; Comer GM;
Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
[TBL] [Abstract][Full Text] [Related]
2. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
[TBL] [Abstract][Full Text] [Related]
3. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
Schepp W; Classen M
Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
5. Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
Meneghelli UG; Zaterka S; de Paula Castro L; Malafaia O; Lyra LG
Am J Gastroenterol; 2000 Jan; 95(1):62-6. PubMed ID: 10638560
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.
Hsu PI; Lo GH; Lo CC; Lin CK; Chan HH; Wu CJ; Shie CB; Tsai PM; Wu DC; Wang WM; Lai KH
World J Gastroenterol; 2004 Dec; 10(24):3666-9. PubMed ID: 15534928
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
Villanueva C; Balanzó J; Torras X; Sáinz S; Soriano G; González D; Vilardell F
Endoscopy; 1995 May; 27(4):308-12. PubMed ID: 7555936
[TBL] [Abstract][Full Text] [Related]
8. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
Wang L; Zhou L; Lin S; Hu H; Xia J
J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
Chen TS; Chang FY; Ng WW; Lee FY; Hwang SJ; Lee SD
Hepatogastroenterology; 1999; 46(28):2372-8. PubMed ID: 10522000
[TBL] [Abstract][Full Text] [Related]
10. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial.
van Rensburg C; Barkun AN; Racz I; Fedorak R; Bornman PC; Beglinger C; Balanzó J; Devière J; Kupcinskas L; Luehmann R; Doerfler H; Schäfer-Preuss S
Aliment Pharmacol Ther; 2009 Mar; 29(5):497-507. PubMed ID: 19053987
[TBL] [Abstract][Full Text] [Related]
12. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.
van Rensburg CJ; Hartmann M; Thorpe A; Venter L; Theron I; Lühmann R; Wurst W
Am J Gastroenterol; 2003 Dec; 98(12):2635-41. PubMed ID: 14687809
[TBL] [Abstract][Full Text] [Related]
13. [Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].
Michel P; Duhamel C; Bazin B; Raoul JL; Person B; Bigard MA; Legoux JL; Sallerin V; Colin R
Gastroenterol Clin Biol; 1994; 18(12):1102-5. PubMed ID: 7750682
[TBL] [Abstract][Full Text] [Related]
14. Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.
Cheng HC; Chang WL; Yeh YC; Chen WY; Tsai YC; Sheu BS
Gastrointest Endosc; 2009 Sep; 70(3):433-9. PubMed ID: 19500787
[TBL] [Abstract][Full Text] [Related]
15. Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.
Bour B; Pariente EA; Hamelin B; Garcia E
Gastroenterol Clin Biol; 1993; 17(5):329-33. PubMed ID: 8349066
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
[TBL] [Abstract][Full Text] [Related]
17. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
Cherniakevich SA; Babkova IV; Mikhalev AI
Klin Med (Mosk); 2002; 80(9):52-4. PubMed ID: 12416227
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
[TBL] [Abstract][Full Text] [Related]
19. [Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
Cardi M; Muttillo IA; Amadori L; Barillari P; Sammartino P; Arnone F; Signorelli C; Bolognese A
Ann Chir; 1997; 51(2):136-9. PubMed ID: 9297869
[TBL] [Abstract][Full Text] [Related]
20. Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Breiter JR; Riff D; Humphries TJ
Am J Gastroenterol; 2000 Apr; 95(4):936-42. PubMed ID: 10763941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
